Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at TRY 1.15T, ahead of BioNTech (TRY 1.08T) and Biogen (TRY 920.9B). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesTRY 1.15T
Median
TRY 101.6B
Combined market value
TRY 42.83T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareTRY 1.15TTRY 10.65TTRY 8,587.74 1.60% up 33% up United States
2BioNTechBNTX · Health CareTRY 1.08TTRY 1.06TTRY 4,280.25 0.47% down 16% down Germany
3BiogenBIIB · Health CareTRY 920.9BTRY 1.87TTRY 12,649.60 0.34% down 49% up United States
4AmgenAMGN · Health CareTRY 436.7BTRY 12.49TTRY 23,097.53 0.95% down 34% up United States
5ModernaMRNA · Health CareTRY 436.3BTRY 4.22TTRY 10,430.79 3.93% down 755% up United States
6argenxARGX · Health CareTRY 369.4BTRY 3.01TTRY 47,791.96 0.36% down 4% up Belgium
7QiagenQGEN · Health CareTRY 190.6BTRY 518.2BTRY 2,509.34 0.12% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareTRY 164.1BTRY 847.1BTRY 8,368.84 0.37% up 20% up United States
9VaxcytePCVX · Health CareTRY 135.5BTRY 474.3BTRY 2,996.08 3.59% down 22% up United States
10ExelixisEXEL · Health CareTRY 109BTRY 843.1BTRY 3,455.07 2.09% up 63% up United States
11Bio-TechneTECH · Health CareTRY 106.3BTRY 575.5BTRY 3,663.38 0.22% down 26% up United States
12RepligenRGEN · Health CareTRY 106.2BTRY 522.9BTRY 8,180.20 0.37% down 5% up United States
13CRISPR TherapeuticsCRSP · Health CareTRY 96.9BTRY 196.4BTRY 2,025.13 0.54% down 21% down Switzerland
14Revolution MedicinesRVMD · Health CareTRY 82.3BTRY 1.77TTRY 8,205.92 2.50% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareTRY 79.7BTRY 523.3BTRY 6,129.35 3.44% down 87% up United States
16Krystal BiotechKRYS · Health CareTRY 61.5BTRY 446.2BTRY 15,058.56 0.22% up 46% up United States
17ImmunovantIMVT · Health CareTRY 43BTRY 346.7BTRY 1,675.08 0.21% down 43% up United States
18CG OncologyCGON · Health CareTRY 38BTRY 355.6BTRY 3,981.65 6.89% down 85% up United States
19Twist BioscienceTWST · Health CareTRY 23.9BTRY 385.2BTRY 5,649.17 6.63% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareTRY 12.4BTRY 277.4BTRY 2,273.79 1.21% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareTRY 11BTRY 232.6BTRY 1,437.01 2.22% up 88% up United States
22Kodiak SciencesKOD · Health CareTRY 7.9BTRY 319.3BTRY 4,882.50 3.90% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareTRY 2.5BTRY 551.9BTRY 4,840.63 0.55% down 37% up United States
24ImmunityBioIBRX · Health Care-TRY 25.2BTRY 335.9BTRY 315.75 4.68% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4390 TRY).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (TRY 1.15T), BioNTech (TRY 1.08T) and Biogen (TRY 920.9B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:23 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of TRY 42.83T as of 18 Nov 2026, 14:23 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.